Nisimura, L.M.; Ferreira, R.R.; Coelho, L.L.; de Oliveira, G.M.; Gonzaga, B.M.; Meuser-Batista, M.; Lannes-Vieira, J.; Araujo-Jorge, T.; Garzoni, L.R.
Vascular Growth Factor Inhibition with Bevacizumab Improves Cardiac Electrical Alterations and Fibrosis in Experimental Acute Chagas Disease. Biology 2023, 12, 1414.
https://doi.org/10.3390/biology12111414
AMA Style
Nisimura LM, Ferreira RR, Coelho LL, de Oliveira GM, Gonzaga BM, Meuser-Batista M, Lannes-Vieira J, Araujo-Jorge T, Garzoni LR.
Vascular Growth Factor Inhibition with Bevacizumab Improves Cardiac Electrical Alterations and Fibrosis in Experimental Acute Chagas Disease. Biology. 2023; 12(11):1414.
https://doi.org/10.3390/biology12111414
Chicago/Turabian Style
Nisimura, Lindice Mitie, Roberto Rodrigues Ferreira, Laura Lacerda Coelho, Gabriel Melo de Oliveira, Beatriz Matheus Gonzaga, Marcelo Meuser-Batista, Joseli Lannes-Vieira, Tania Araujo-Jorge, and Luciana Ribeiro Garzoni.
2023. "Vascular Growth Factor Inhibition with Bevacizumab Improves Cardiac Electrical Alterations and Fibrosis in Experimental Acute Chagas Disease" Biology 12, no. 11: 1414.
https://doi.org/10.3390/biology12111414
APA Style
Nisimura, L. M., Ferreira, R. R., Coelho, L. L., de Oliveira, G. M., Gonzaga, B. M., Meuser-Batista, M., Lannes-Vieira, J., Araujo-Jorge, T., & Garzoni, L. R.
(2023). Vascular Growth Factor Inhibition with Bevacizumab Improves Cardiac Electrical Alterations and Fibrosis in Experimental Acute Chagas Disease. Biology, 12(11), 1414.
https://doi.org/10.3390/biology12111414
